Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (34)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rooney, M.
Right arrow Articles by Woo, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rooney, M.
Right arrow Articles by Woo, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2000; 39: 432-438
© 2000 British Society for Rheumatology

Tumour necrosis factor alpha and its soluble receptors in juvenile chronic arthritis

M. Rooney, H. Varsani, K. Martin, P. R. Lombard1, J.-M. Dayer1 and P. Woo

Centre for Paediatric and Adolescent Rheumatology, UCL, London, UK and
1 Division of Immunology and Allergy, University Hospital, Geneva, Switzerland

Objective. To identify possible imbalance of tumour necrosis factor alpha (TNF{alpha}) and its soluble receptors in the different subgroups of juvenile chronic arthritis (JCA).

Methods. Serum and synovial fluid samples from 45 children were examined, 25 pauciarticular JCA, 13 polyarticular JCA and seven spondyloarthropathy. TNF{alpha}, sTNFRI and sTNFRII levels were measured by EASIA and enzyme-linked immunosorbent assay (ELISA). Analysis of the results was carried out using non-parametric tests: Kruskal–Wallis one-way analysis of variance was used to compare the three clinical subgroups; the Mann–Whitney U-test was used to compare group medians.

Results. Thirty-three serum samples were assayed for TNF{alpha}. There was no significant difference between the three groups using the Kruskal–Wallis analysis of variance. Analysis of synovial fluid TNF levels showed significantly lower levels in the spondyloarthropathy group compared with the pauciarticular JCA (P = 0.01) and the polyarticular group (P = 0.002). Significantly higher levels of sTNFRI were observed in the synovial fluid of the polyarticular JCA group compared with the pauciarticular JCA group (P = 0.004) and similarly for sTNFRII (P = 0.03). Molar ratios were calculated for TNF vs sTNFRI. The sTNFRI/TNF{alpha} ratio was significantly higher in the spondyloarthropathy group compared with the pauci- (P 0.003) and the polyarticular JCA subgroups (P = 0.003). The combined soluble receptor levels expressed as molar ratio to TNF again showed a significantly higher ratio in the spondyloarthropathy group compared with the pauciarticular group (P = 0.01) and compared with the polyarticular group (P = 0.05).

Conclusion. These results suggest that the increased joint destruction observed in polyarticular disease compared with the other two subtypes may be related to the lower sTNFR/TNF{alpha} ratios observed.

KEY WORDS: Juvenile chronic arthritis, Synovial fluid, Cytokines, Tumour necrosis factor alpha, Soluble TNF receptors.

Correspondence to: P. Woo, Centre for Paediatric and Adolescent Rheumatology, UCL, Department of Molecular Pathology, The Windeyer Institute of Medical Sciences, 46 Cleveland Street, London, W1P 6DB, UK.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
The Journal of RheumatologyHome page
H. S. ZENG, X. Y. CHEN, and X. P. LUO
The Association with the -159C/T Polymorphism in the Promoter Region of the CD14 Gene and Juvenile Idiopathic Arthritis in a Chinese Han Population
J Rheumatol, September 1, 2009; 36(9): 2025 - 2028.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Iwamoto, S.-i. Iwai, K. Tsujiyama, C. Kurahashi, K. Takeshita, M. Naoe, A. Masunaga, Y. Ogawa, K. Oguchi, and A. Miyazaki
TNF-{alpha} Drives Human CD14+ Monocytes to Differentiate into CD70+ Dendritic Cells Evoking Th1 and Th17 Responses
J. Immunol., August 1, 2007; 179(3): 1449 - 1457.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
V. E. MacRae, C. Farquharson, and S. F. Ahmed
The pathophysiology of the growth plate in juvenile idiopathic arthritis
Rheumatology, January 1, 2006; 45(1): 11 - 19.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
K. Oen, P. N. Malleson, D. A. Cabral, A. M. Rosenberg, R. E. Petty, P. Nickerson, and M. Reed
Cytokine genotypes correlate with pain and radiologically defined joint damage in patients with juvenile rheumatoid arthritis
Rheumatology, September 1, 2005; 44(9): 1115 - 1121.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
N Wilkinson, G Jackson, and J Gardner-Medwin
Biologic therapies for juvenile arthritis
Arch. Dis. Child., March 1, 2003; 88(3): 186 - 191.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
E. Zeggini, W. Thomson, A. Alansari, W. Ollier, and R. Donn
Tumour necrosis factor receptor II polymorphism and juvenile idiopathic arthritis
Rheumatology, April 1, 2002; 41(4): 462 - 465.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.